Methyl 6-methyl-3-(p-tolyl)isoxazolo[5,4-b]pyridine-4-carboxylate

Catalog No. :
ACSHMU142
CAS No. :
1018125-65-9
Molecular Formula :
C16H14N2O3
Molecular Weight :
282.30

IUPAC Name:methyl 6-methyl-3-(p-tolyl)isoxazolo[5,4-b]pyridine-4-carboxylate

Methyl 6-methyl-3-(p-tolyl)isoxazolo[5,4-b]pyridine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$219.00Login to see priceInquiryInquiry
5g97%$654.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-methyl-3-(p-tolyl)isoxazolo[5,4-b]pyridine-4-carboxylate
IUPAC Namemethyl 6-methyl-3-(p-tolyl)isoxazolo[5,4-b]pyridine-4-carboxylate
Molecular FormulaC16H14N2O3
Molecular Weight282.30
SMILESO=C(C1=C2C(ON=C2C3=CC=C(C)C=C3)=NC(C)=C1)OC
InChI KeyZUZFHRGVYKSBNM-UHFFFAOYSA-N
Synonymmethyl 6-methyl-3-(4-methylphenyl)isoxazolo[5,4-b]pyridine-4-carboxylate;Isoxazolo[5,4-b]pyridine-4-carboxylic acid, 6-methyl-3-(4-methylphenyl)-, methyl ester
CAS No.1018125-65-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSHMU142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYXCW831 route compound structure diagram
    ACYXCW8315720-05-8 In Stock
  4. Then
  5. ACSHMU142 route product structure diagram
    ACSHMU1421018125-65-9
Inquiry

2. ACSHMU142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYXCW831 route compound structure diagram
    ACYXCW8315720-05-8 In Stock
  4. Then
  5. ACSHMU142 route product structure diagram
    ACSHMU1421018125-65-9
Inquiry

Comments (0)